PTH and X-linked hypophosphatemia: As for younger children, members of our group used biochemical analyses of serum phosphate, 25-hydroxyvitamin D (25(OH)D), calcium, parathyroid hormone (PTH) and TmP/GFR to monitor the treatment response to burosumab in adolescents and young adults with XLH.